{"database": "lobbying", "table": "lobbying_activities", "rows": [[3043611, "355b4629-43a6-411b-90db-68fc42665e5a", "Q3", "INFUSION PROVIDERS ALLIANCE", 401105750, "INFUSION PROVIDERS ALLIANCE", 2023, "third_quarter", "MMM", "Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE", null, 27000, 0, 0, "2023-09-29T09:57:41-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3043611"], "units": {}, "query_ms": 49.02843083254993, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}